Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Decker, A. Kikowatz, G. Becher, J. I. Baumbach (Berlin, Dortmund, Germany). Fractionated investigation of gaseous compounds in exhaled breath with a GC/IMS-system. Eur Respir J 2007; 30: Suppl. 51, 539

Member's Comments

No comment yet.

Related content which might interest you: Fractionated sampling of exhaled breath condensate Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds Source: Eur Respir J 2005; 26: Suppl. 49, 373s Year: 2005 Parameters of oxidation in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 470s Year: 2004 Methodology of exhaled breath condensate Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide Year: 2009 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Future perspectives on exhaled biomarkers Source: Eur Respir Monogr 2010; 49: 237-246 Year: 2010 Influence of ambient air on NMR-based metabolomics of exhaled breath condensates Source: Eur Respir J 2012; 40: 1294-1296 Year: 2012 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Exhaled breath condensate contains more than only volatiles Source: Eur Respir J 2003; 22: 187-188 Year: 2003 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Exhaled volatile organic compounds in nonrespiratory diseases Source: Eur Respir Monogr 2010; 49: 140-151 Year: 2010 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007 Endogenous and exogenous metabolites in exhaled breath condensate in asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002